A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects-Reference-Cited by-同舟云学术

A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects

Published:2018-05 Issue: Volume:105 Page:53-69
ISSN:0531-5565
Container-title:Experimental Gerontology
language:en
Short-container-title:Experimental Gerontology

Author:

Kraig Ellen,Linehan Leslie A.,Liang Hanyu,Romo Terry Q.,Liu Qianqian,Wu Yubo,Benavides Adriana D.,Curiel Tyler J.,Javors Martin A.,Musi Nicolas,Chiodo Laura,Koek Wouter,Gelfond Jonathan A.L.,Kellogg Dean L.

Funder

UTHSA IIMS-CTSA

NIDDK

American Diabetes Association

San Antonio Claude D. Pepper Older Americans Independence Center

San Antonio Nathan Shock Center of Excellence in the Biology of Aging

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Genetics,Molecular Biology,Ageing,Biochemistry

Reference65 articles.

1. Rapamycin: an InhibiTOR of aging emerges from the soil of Easter Island;Apelo;J. Gerontol. A Biol. Sci. Med. Sci.,2016